Our in vivo results suggested that EUG has the potential to alleviate pancreatic β cell damage by activating the NRF2 pathway, thereby augmenting insulin secretion and ameliorating the prognosis of T1DM. This evidence concerns the gene INS and type 1 diabetes mellitus.